Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARE: Amoxicillin Duration for Pneumonia in Children
NCT06291012Phase 4Not yet recruiting
- Sponsor
- CHU Montpellier
- Start
- Sep 2024
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin in community acquired pneumonia (CAP), sponsored by CHU Montpellier. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
amoxicillin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT06291012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06291012.